
Biohaven rose 91.1% from $7.95 to $15.19, ahead of the S&P 500's +11.2%. Its worst day was Sep 10 (−14.7%), and its low came Nov 12 at $7.95.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Biohaven shares rose 14.3%, while the S&P 500 fell 0.8%.
+14.3% · S&P 500 −0.8%
Biohaven shares rose 22.0%, while the S&P 500 fell 0.3%.
+22.0% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
EPS of $-1.21 missed the $-1.06 estimate on $0.00 revenue (est. $1.5M).
−9.7% · S&P 500 −0.9%
EPS of $-0.69 beat the $-0.78 estimate on $0.00 revenue (est. $8.3M).
−4.2% · S&P 500 +0.8%
Biohaven shares rose 14.2%, while the S&P 500 fell 0.3%.
+14.2% · S&P 500 −0.3%
EPS of $-0.78 missed the $-0.64 estimate on $0.00 revenue.
−0.3% · S&P 500 −0.3%
Biohaven closed at its highest level of the year, 113.2% above where the year started.
+17.9% · S&P 500 0.0%
Biohaven shares rose 15.6%, while the S&P 500 rose 0.9%.
+15.6% · S&P 500 +0.9%
Biohaven shares rose 25.0%, while the S&P 500 fell 1.2%.
+25.0%, the year's best day, on 31M shares, the year's heaviest volume · S&P 500 −1.2%
EPS of $-0.73 missed the $-0.03 estimate on $0.00 revenue (est. $110.0M).
−6.5% · S&P 500 −1.8%
Where it ended: a close of $15.19 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 11, 2027 (EPS est. $0.28, revenue est. $131.1M).
Nothing in the past 12 months.
All BHVN dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BHVN and SPY from Benzinga historical bars. Not investment advice.